Skip to main content
U.S. flag

An official website of the United States government

Return to Search

Guidance for Patient Safety Rule Patient Safety and Quality Improvement Act of 2005

This page provides guidance Guidance for Patient Safety Rule Patient Safety and Quality Improvement Act of 2005 under HIPAA.

Final

Issued by: Office for Civil Rights (OCR)

Issue Date: June 30, 1905

Guidance for Patient Safety Rule

Patient Safety and Quality Improvement Act of 2005

HHS Guidance Regarding Patient Safety Work Product and Providers' External Obligations (May 2016) - PDF

SUMMARY: This notice sets forth guidance for patient safety organizations (PSOs) and providers regarding questions that have arisen about the Patient Safety and Quality Improvement Act of 2005, 42 USC 299b-21–b-26 (Patient Safety Act), and its implementing regulation, the Patient Safety and Quality Improvement Final Rule, 42 CFR Part 3 (Patient Safety Rule).  In particular, this Patient Safety and Quality Improvement Act of 2005 – Guidance Regarding Patient Safety Work Product and Providers’ External Obligations (Guidance) is intended to provide clarity in response to recurring questions about what information that a provider creates or assembles can become patient safety work product (PSWP). This Guidance also clarifies how providers can satisfy external obligations related to information collection activities consistent with the Patient Safety Act and Patient Safety Rule.

HHS Guidance Regarding Patient Safety Organizations’ Reporting Obligations to the FDA (December 2010) - PDF

SUMMARY:  The Guidance states that a PSO that is a component of a parent organization that includes an FDA-regulated entity cannot create a conflict of interest for its parent organization by extending PSWP protections to information that the regulated entity is required to report to the FDA under the FDCA. Therefore, for such an entity to become listed as a component PSO, the entity must agree to disclose PSWP to both its parent and the FDA, when required.

The Patient Safety Guidance applies to:

  1. All entities that have mandatory FDA-reporting obligations under the Food, Drug and Cosmetic Act (FDCA) or

  2. Entities that are organizationally related to such FDA-regulated reporting entities (e.g., parent organizations, subsidiaries, sibling organizations).

HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.

DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.